IMTX
Immatics N.V.
Price Chart
Latest Quote
$7.22
+0.07 (+0.98%)
Current Price
| Previous Close | $7.15 |
| Open | $7.19 |
| Day High | $7.38 |
| Day Low | $7.00 |
| Volume | 509,822 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 152.23M |
| Total Debt | $16.28M |
| Cash Equivalents | $438.37M |
| Revenue | $46.48M |
| Net Income | $-230.19M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.10B |
| EPS (TTM) | $-1.83 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $598.59M |
| Sales | $46.48M |
| Income | $-230.19M |
| Book/sh | $3.28 |
| Cash/sh | $2.58 |
| Employees | 704 |
Financial Ratios
| Quick Ratio | 7.02 |
| Current Ratio | 7.54 |
| Debt/Eq | 3.65 |
Returns & Margins
| ROA | -26.92% |
| ROE | -47.80% |
| Operating Margin | -734.95% |
Ownership
| Insider Ownership | 15.78% |
| Institutional Ownership | 66.81% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.58 |
| P/S | 26.35 |
| P/B | 2.20 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $16.97 |
Technical Indicators
| SMA20 | $7.43 |
| SMA50 | $8.35 |
| SMA200 | $9.62 |
| RSI | 46.20 |
| ATR | 0.4355 |
| Shares Float | 70.12M |
| Short Float | 3.36% |
| Short Ratio | 5.07 |
| Volatility | 1.36 |
| Rel Volume | 0.48 |
Performance History
| Week | -3.86% |
| Month | -15.06% |
| Quarter | -19.69% |
| 6 Months | -37.70% |
| YTD | -30.91% |
| Year | -29.08% |
| 3 Years | -17.20% |
| 5 Years | -45.47% |
| 10 Years | -24.79% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $7.22 | 509,822 |
| 2026-10-26 | $7.15 | 756,100 |
| 2026-10-23 | $7.31 | 696,000 |
| 2026-10-22 | $7.54 | 621,000 |
| 2026-10-21 | $7.69 | 1,980,400 |
| 2026-10-20 | $7.51 | 1,487,300 |
| 2026-10-19 | $7.05 | 967,100 |
| 2026-10-16 | $6.73 | 1,154,900 |
| 2026-10-15 | $7.14 | 1,627,800 |
| 2026-10-14 | $7.00 | 1,566,300 |
| 2026-10-13 | $6.83 | 928,000 |
| 2026-10-12 | $7.21 | 750,400 |
| 2026-10-09 | $7.43 | 1,371,300 |
| 2026-10-08 | $7.37 | 604,700 |
| 2026-10-07 | $7.45 | 926,000 |
| 2026-10-06 | $7.50 | 974,400 |
| 2026-10-05 | $7.73 | 554,100 |
| 2026-10-02 | $7.59 | 1,256,500 |
| 2026-10-01 | $8.44 | 639,700 |
| 2026-09-30 | $8.78 | 1,898,600 |
| 2026-09-29 | $8.56 | 644,300 |
| 2026-09-28 | $8.50 | 1,467,500 |
About Immatics N.V.
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in TÃŧbingen, Germany.
đ° Latest News
No news articles available at the moment. Check back later for updates on IMTX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $54,231,460 | $175,095,505 | $60,670,786 | $194,192,134 |
| Operating Revenue | $54,231,460 | $175,095,505 | $60,670,786 | $194,192,134 |
| Expenses | ||||
| Interest Expense | $1,062,921 | $995,506 | $933,708 | $1,166,292 |
| Total Expenses | $258,743,819 | $218,483,145 | $174,968,538 | $160,535,954 |
| Other Income Expense | $-36,688,764 | $40,276,404 | $-9,306,742 | $11,959,551 |
| Net Non Operating Interest Income Expense | $18,239,326 | $27,095,505 | $14,622,472 | $1,615,730 |
| Interest Expense Non Operating | $1,062,921 | $995,506 | $933,708 | $1,166,292 |
| Operating Expense | $258,743,819 | $218,483,145 | $174,968,538 | $160,535,954 |
| Other Operating Expenses | $-5,319,101 | $-87,640 | $-1,279,775 | $-29,213 |
| General And Administrative Expense | $57,510,112 | $52,189,887 | $42,919,101 | $40,588,764 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-220,726,965 | $17,098,876 | $-106,347,190 | $31,126,966 |
| Net Interest Income | $18,239,326 | $27,095,505 | $14,622,472 | $1,615,730 |
| Interest Income | $19,302,247 | $28,091,011 | $15,556,180 | $2,782,022 |
| Normalized Income | $-184,405,947 | $-11,614,996 | $-97,265,456 | $23,245,259 |
| Net Income From Continuing And Discontinued Operation | $-220,726,965 | $17,098,876 | $-106,347,190 | $31,126,966 |
| Total Operating Income As Reported | $-204,512,359 | $-43,387,640 | $-114,297,752 | $33,656,180 |
| Net Income Common Stockholders | $-220,726,965 | $17,098,876 | $-106,347,190 | $31,126,966 |
| Net Income | $-220,726,965 | $17,098,876 | $-106,347,190 | $31,126,966 |
| Net Income Including Noncontrolling Interests | $-220,726,965 | $17,098,876 | $-106,347,190 | $31,126,966 |
| Net Income Continuous Operations | $-220,726,965 | $17,098,876 | $-106,347,190 | $31,126,966 |
| Pretax Income | $-222,961,797 | $23,984,270 | $-108,982,022 | $47,231,460 |
| Interest Income Non Operating | $19,302,247 | $28,091,011 | $15,556,180 | $2,782,022 |
| Operating Income | $-204,512,359 | $-43,387,640 | $-114,297,752 | $33,656,180 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-1.81 | $0.16 | $-1.33 | $0.62 |
| Basic EPS | $-1.81 | $0.16 | $-1.33 | $0.63 |
| Other | ||||
| Tax Effect Of Unusual Items | $-367,746 | $11,562,532 | $-225,007 | $4,077,844 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-171,277,527 | $-1,560,674 | $-90,613,483 | $44,266,292 |
| Total Unusual Items | $-36,688,764 | $40,276,404 | $-9,306,742 | $11,959,551 |
| Total Unusual Items Excluding Goodwill | $-36,688,764 | $40,276,404 | $-9,306,742 | $11,959,551 |
| Reconciled Depreciation | $13,932,584 | $13,735,955 | $8,128,090 | $7,828,090 |
| EBITDA (Bullshit earnings) | $-207,966,291 | $38,715,730 | $-99,920,224 | $56,225,842 |
| EBIT | $-221,898,875 | $24,979,775 | $-108,048,314 | $48,397,753 |
| Diluted Average Shares | $137,470,150 | $119,994,494 | $90,501,889 | $76,637,385 |
| Basic Average Shares | $137,470,150 | $118,814,526 | $90,501,889 | $75,268,860 |
| Diluted NI Availto Com Stockholders | $-220,726,965 | $17,098,876 | $-106,347,190 | $31,126,966 |
| Tax Provision | $-2,234,831 | $6,885,393 | $-2,634,831 | $16,104,494 |
| Gain On Sale Of Security | $-36,688,764 | $40,276,404 | $-9,306,742 | $11,959,551 |
| Research And Development | $206,552,808 | $166,380,898 | $133,329,213 | $119,976,404 |
| Selling General And Administration | $57,510,112 | $52,189,887 | $42,919,101 | $40,588,764 |
| Other Gand A | $27,975,281 | $25,802,247 | $42,919,101 | $40,588,764 |
| Salaries And Wages | $29,534,831 | $26,387,640 | $24,471,910 | $23,508,989 |
| Minority Interests | - | - | - | $0 |
| Restructuring And Mergern Acquisition | - | - | - | $0 |
Fetched: 2026-10-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $542,153,930 | $644,059,547 | $242,803,370 | $226,652,808 |
| Total Assets | $631,839,323 | $782,186,513 | $572,994,379 | $458,224,717 |
| Total Non Current Assets | $65,538,202 | $74,821,348 | $68,084,269 | $34,456,180 |
| Other Non Current Assets | $864,045 | $1,030,337 | $677,528 | $2,859,551 |
| Non Current Prepaid Assets | $1,214,607 | $374,157 | $1,588,764 | $2,141,573 |
| Goodwill And Other Intangible Assets | $1,777,528 | $1,830,337 | $1,711,236 | $1,833,708 |
| Other Intangible Assets | $1,777,528 | $1,830,337 | $1,711,236 | $1,833,708 |
| Current Assets | $566,301,121 | $707,365,165 | $504,910,110 | $423,768,537 |
| Other Current Assets | $16,707,865 | $7,089,888 | $7,998,876 | $15,548,315 |
| Prepaid Assets | $14,516,854 | $13,537,079 | $11,931,461 | $11,741,573 |
| Receivables | $7,731,461 | $7,578,652 | $6,446,067 | $1,248,315 |
| Taxes Receivable | $878,652 | $997,753 | $1,847,191 | $1,158,427 |
| Accounts Receivable | $6,852,809 | $6,580,899 | $4,598,876 | $1,248,315 |
| Cash Cash Equivalents And Short Term Investments | $527,344,941 | $679,159,547 | $478,533,705 | $406,971,908 |
| Cash And Cash Equivalents | $388,671,908 | $266,008,987 | $245,474,156 | $166,875,280 |
| Hedging Assets Current | - | - | - | - |
| Other Receivables | - | - | - | - |
| Debt | ||||
| Total Debt | $17,567,416 | $18,205,618 | $17,305,618 | $16,361,798 |
| Long Term Debt And Capital Lease Obligation | $14,469,663 | $15,002,247 | $14,379,775 | $13,935,955 |
| Current Debt And Capital Lease Obligation | $3,097,753 | $3,203,371 | $2,925,843 | $2,425,843 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $87,907,865 | $136,296,629 | $328,479,774 | $229,738,201 |
| Total Non Current Liabilities Net Minority Interest | $39,579,775 | $59,906,741 | $152,578,651 | $110,129,213 |
| Non Current Deferred Liabilities | $25,110,112 | $44,904,494 | $138,194,381 | $96,146,067 |
| Non Current Deferred Taxes Liabilities | $4,277,528 | $6,521,348 | $8,388,764 | $11,023,595 |
| Current Liabilities | $48,328,090 | $76,389,887 | $175,901,123 | $119,608,988 |
| Other Current Liabilities | $1,741,573 | $3,580,899 | $21,579,775 | $29,528,090 |
| Current Deferred Liabilities | $17,770,786 | $40,346,067 | $112,810,112 | $72,985,393 |
| Payables And Accrued Expenses | $23,800,000 | $27,485,393 | $37,150,562 | $14,669,663 |
| Payables | $3,022,472 | $15,596,629 | $17,442,697 | $14,669,663 |
| Total Tax Payable | $2,640,449 | $4,234,831 | $8,829,213 | $8,678,652 |
| Income Tax Payable | $35,955 | $1,978,652 | $4,829,213 | $4,829,213 |
| Accounts Payable | $382,022 | $11,361,798 | $8,613,483 | $14,669,663 |
| Other Non Current Liabilities | - | - | $4,494 | $47,191 |
| Equity | ||||
| Common Stock Equity | $543,931,458 | $645,889,884 | $244,514,606 | $228,486,516 |
| Total Equity Gross Minority Interest | $543,931,458 | $645,889,884 | $244,514,606 | $228,486,516 |
| Stockholders Equity | $543,931,458 | $645,889,884 | $244,514,606 | $228,486,516 |
| Gains Losses Not Affecting Retained Earnings | $-9,653,933 | $1,158,427 | $-1,838,202 | $-1,664,045 |
| Other Equity Adjustments | $-9,653,933 | $1,158,427 | $-1,838,202 | $-1,664,045 |
| Retained Earnings | $-883,132,580 | $-662,405,615 | $-679,504,491 | $-573,157,301 |
| Other | ||||
| Ordinary Shares Number | $150,642,058 | $136,573,223 | $95,121,111 | $86,146,852 |
| Share Issued | $150,642,058 | $136,573,223 | $95,121,111 | $86,146,852 |
| Tangible Book Value | $542,153,930 | $644,059,547 | $242,803,370 | $226,652,808 |
| Invested Capital | $543,931,458 | $645,889,884 | $244,514,606 | $228,486,516 |
| Working Capital | $517,973,031 | $630,975,278 | $329,008,987 | $304,159,549 |
| Capital Lease Obligations | $17,567,416 | $18,205,618 | $17,305,618 | $16,361,798 |
| Total Capitalization | $543,931,458 | $645,889,884 | $244,514,606 | $228,486,516 |
| Additional Paid In Capital | $1,435,211,229 | $1,305,770,780 | $924,905,613 | $802,446,063 |
| Capital Stock | $1,506,742 | $1,366,292 | $951,685 | $861,798 |
| Common Stock | $1,506,742 | $1,366,292 | $951,685 | $861,798 |
| Non Current Deferred Revenue | $20,832,584 | $38,383,146 | $129,805,617 | $85,122,471 |
| Long Term Capital Lease Obligation | $14,469,663 | $15,002,247 | $14,379,775 | $13,935,955 |
| Current Deferred Revenue | $17,770,786 | $40,346,067 | $112,810,112 | $72,985,393 |
| Current Capital Lease Obligation | $3,097,753 | $3,203,371 | $2,925,843 | $2,425,843 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,917,978 | $1,774,157 | $1,434,831 | $905,618 |
| Current Accrued Expenses | $20,777,528 | $11,888,764 | $19,707,865 | $10,911,236 |
| Net PPE | $61,682,022 | $71,586,516 | $64,106,741 | $29,762,921 |
| Accumulated Depreciation | $-33,441,573 | $-36,025,843 | $-25,691,011 | $-23,013,483 |
| Gross PPE | $95,123,595 | $107,612,359 | $89,797,752 | $52,776,404 |
| Leases | $32,319,101 | $35,300,000 | $28,553,932 | $4,310,112 |
| Other Properties | $38,662,921 | $43,233,708 | $34,392,135 | $39,849,438 |
| Machinery Furniture Equipment | $9,997,753 | $14,298,876 | $12,414,607 | $8,616,854 |
| Buildings And Improvements | $14,143,820 | $14,779,775 | $14,437,079 | $13,942,697 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $138,673,033 | $413,150,560 | $233,059,549 | $240,096,628 |
| Current Provisions | - | - | - | - |
Fetched: 2026-10-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-206,102,246 | $-196,078,651 | $-14,302,247 | $105,523,595 |
| Operating Activities | ||||
| Operating Cash Flow | $-198,456,179 | $-177,561,797 | $20,480,899 | $112,506,741 |
| Cash Flow From Continuing Operating Activities | $-198,456,179 | $-177,561,797 | $20,480,899 | $112,506,741 |
| Operating Gains Losses | $37,249,438 | $-40,414,607 | $9,876,404 | $-8,979,775 |
| Investing Activities | ||||
| Capital Expenditure | $-7,646,067 | $-18,516,854 | $-34,783,146 | $-6,983,146 |
| Investing Cash Flow | $230,097,752 | $-171,221,347 | $-35,267,416 | $-235,720,224 |
| Cash Flow From Continuing Investing Activities | $230,097,752 | $-171,221,347 | $-35,267,416 | $-235,720,224 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $120,573,033 | $385,404,492 | $101,577,528 | $151,105,617 |
| Financing Cash Flow | $109,385,393 | $359,195,504 | $94,961,797 | $138,999,999 |
| Cash Flow From Continuing Financing Activities | $109,385,393 | $359,195,504 | $94,961,797 | $138,999,999 |
| Net Other Financing Charges | $-7,862,921 | $-23,948,314 | $-2,291,011 | $-8,911,236 |
| Net Common Stock Issuance | $120,573,033 | $385,404,492 | $101,577,528 | $151,105,617 |
| Common Stock Issuance | $120,573,033 | $385,404,492 | $101,577,528 | $151,105,617 |
| Other | ||||
| Repayment Of Debt | $-3,324,719 | $-2,260,674 | $-4,324,719 | $-3,194,382 |
| End Cash Position | $388,671,908 | $266,008,987 | $245,474,156 | $166,875,280 |
| Beginning Cash Position | $266,008,987 | $245,474,156 | $166,875,280 | $149,431,460 |
| Effect Of Exchange Rate Changes | $-18,364,045 | $10,122,472 | $-1,576,404 | $1,657,303 |
| Changes In Cash | $141,026,966 | $10,412,359 | $80,175,280 | $15,786,517 |
| Net Issuance Payments Of Debt | $-3,324,719 | $-2,260,674 | $-4,324,719 | $-3,194,382 |
| Net Long Term Debt Issuance | $-3,324,719 | $-2,260,674 | $-4,324,719 | $-3,194,382 |
| Long Term Debt Payments | $-3,324,719 | $-2,260,674 | $-4,324,719 | $-3,194,382 |
| Net Investment Purchase And Sale | $237,743,819 | $-152,706,741 | $-652,809 | $-228,795,504 |
| Sale Of Investment | $617,819,098 | $353,303,369 | $466,004,492 | $14,264,045 |
| Purchase Of Investment | $-380,075,279 | $-506,010,110 | $-466,657,301 | $-243,059,549 |
| Net Intangibles Purchase And Sale | $-277,528 | $-233,708 | $-177,528 | $-535,955 |
| Purchase Of Intangibles | $-277,528 | $-233,708 | $-177,528 | $-535,955 |
| Net PPE Purchase And Sale | $-7,368,539 | $-18,280,899 | $-34,437,078 | $-6,388,764 |
| Sale Of PPE | $0 | $2,247 | $168,539 | $58,427 |
| Purchase Of PPE | $-7,368,539 | $-18,283,146 | $-34,605,618 | $-6,447,191 |
| Taxes Refund Paid | $-4,977,528 | $-14,716,854 | $-3,325,843 | $-251,685 |
| Interest Received Cfo | $30,131,461 | $17,533,708 | $11,423,595 | $1,852,809 |
| Interest Paid Cfo | $-1,062,921 | $-995,506 | $-325,843 | $-780,899 |
| Change In Working Capital | $-49,398,876 | $-169,415,729 | $95,044,943 | $41,862,921 |
| Change In Other Working Capital | $-42,264,045 | $-168,250,561 | $96,628,089 | $51,189,887 |
| Change In Other Current Assets | $-6,862,921 | $816,854 | $1,767,416 | $-8,844,944 |
| Change In Receivables | $-271,910 | $-1,982,022 | $-3,350,562 | $-482,022 |
| Changes In Account Receivables | $-271,910 | $-1,982,022 | $-3,350,562 | $-482,022 |
| Other Non Cash Items | $-18,239,326 | $-27,095,505 | $-14,622,472 | $-1,615,730 |
| Stock Based Compensation | $16,870,786 | $19,822,472 | $23,264,045 | $25,359,550 |
| Deferred Tax | $-2,234,831 | $6,885,393 | $-2,634,831 | $16,104,494 |
| Deferred Income Tax | $-2,234,831 | $6,885,393 | $-2,634,831 | $16,104,494 |
| Depreciation Amortization Depletion | $13,932,584 | $13,735,955 | $8,128,090 | $7,828,090 |
| Depreciation And Amortization | $13,932,584 | $13,735,955 | $8,128,090 | $7,828,090 |
| Gain Loss On Investment Securities | $-1,943,820 | $-19,397,753 | $2,335,955 | $-12,297,753 |
| Net Foreign Currency Exchange Gain Loss | $38,350,562 | $-21,017,977 | $7,708,989 | $3,317,978 |
| Gain Loss On Sale Of PPE | $842,697 | $1,124 | $-168,539 | $0 |
| Net Income From Continuing Operations | $-220,726,965 | $17,098,876 | $-106,347,190 | $31,126,966 |
| Change In Payables And Accrued Expense | - | - | - | - |
| Change In Payable | - | - | - | - |
| Change In Account Payable | - | - | - | - |
Fetched: 2026-10-20